HORSHAM, Pa.--(BUSINESS WIRE)--NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., (NASDAQ: QSII) today kicked off its annual User Group Meeting (NextGen™ ONE UGM) at the Mandalay Bay Resort in Las Vegas, NV.
This year there will be a focus on educating clients on the Medicare Access and CHIP Reauthorization Act (MACRA) and its final rule released October 14, 2016, as well as CMS’ Quality Payment Program (QPP). The four-day conference will include numerous educational sessions, deeper dives into MACRA, and how to succeed in making the transition to value-based care.
While at UGM, clients can take a value-based care survey that will help them determine their practices’ readiness for that transition. They can also meet one-on-one with NextGen Healthcare consultants whose goal is to help clients create a customized plan to succeed under new reimbursement guidelines. NextGen ONE UGM 2016 also offers hundreds of educational sessions for clients and demonstrations of new and existing technology solutions. Clients can visit a hands-on Learning Lab, staffed with technology professionals, where they can use the latest solutions from NextGen Healthcare and get practical tips to optimize their experience and results.
To launch the conference, NextGen Healthcare's President and Chief Executive Officer, Rusty Frantz, will address attendees in a general session that will discuss how the company is partnering with clients to help them succeed. He will also discuss how the company continues to invest in new services and solutions to deliver value and an exceptional client experience.
"As the president and CEO of NextGen Healthcare, my highest priority is to evaluate the experience we offer our clients, where our greatest strengths lie, and opportunities where we can provide additional value," said Frantz. "NextGen ONE UGM provides a great opportunity to present our strategic vision for the company and the services and solutions clients need to move from fee-for-service to fee-for-value successfully. The MACRA law is complex and we are here to help our clients understand it and ease their transition."
Keynote speaker Mel Robbins, best-selling author, serial entrepreneur, and award-winning CNN analyst, joins an impressive list of presenters covering a wide variety of industry topics, including interoperability, patient engagement, usability and physician satisfaction; managed cloud services; cost containment and risk sharing; population health, regulatory compliance, and revenue-cycle management.
Clients will also get a chance to see the company’s new NextGen® Ambulatory EHR and NextGen® Practice Management version 5.8 UD3, released October 28, 2016. This new version adds functionality to improve usability and reduce clicks in common office workflows. Providers and clinicians can spend more time focused on patients and less time on the computer. It includes features that make patient information available with zero clicks. Its interoperability provides a more longitudinal and complete view of the patient to enable better care.
“I’m very excited about the GR of 5.8 UD3,” said Frantz. “It’s our best quality release ever with an enhanced user experience and will be a pathway to help clients successfully manage the CMS Quality Payment Program.”
For more information on NextGen ONE UGM 2016, click here: http://www.oneugm.com/
About NextGen Healthcare
NextGen Healthcare, a wholly owned subsidiary of Quality Systems, Inc., helps ambulatory care organizations succeed in value-based care by empowering them to nurture measurably healthier patients and communities at a lower cost. It does this with deep clinical, financial, operational, and regulatory expertise, using consulting and educational services coupled with a robust technology portfolio of flexible, scalable, and cost-effective ambulatory solutions; including a certified EHR, practice management, interoperability, care management, patient engagement and population health management, analytics, e-transaction, and revenue cycle management solutions. For more information, visit www.nextgen.com. Follow NextGen Healthcare on Twitter, Facebook, or LinkedIn.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments in the healthcare sector and regulatory framework, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income, and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2016 and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.